|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9286
|
|
pubmed:dateCreated |
2001-10-3
|
|
pubmed:abstractText |
Surgery is the main treatment for localised renal cell carcinoma, but use of radical nephrectomy for metastatic disease is highly controversial. We aimed to establish whether radical nephrectomy done before interferon-alfa-based immunotherapy improved time to progression and overall survival (primary endpoints) compared with interferon alfa alone.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
22
|
|
pubmed:volume |
358
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
966-70
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11583750-Adult,
pubmed-meshheading:11583750-Aged,
pubmed-meshheading:11583750-Antineoplastic Agents,
pubmed-meshheading:11583750-Carcinoma, Renal Cell,
pubmed-meshheading:11583750-Female,
pubmed-meshheading:11583750-Humans,
pubmed-meshheading:11583750-Immunotherapy,
pubmed-meshheading:11583750-Interferon-alpha,
pubmed-meshheading:11583750-Kidney Neoplasms,
pubmed-meshheading:11583750-Male,
pubmed-meshheading:11583750-Middle Aged,
pubmed-meshheading:11583750-Nephrectomy,
pubmed-meshheading:11583750-Recombinant Proteins,
pubmed-meshheading:11583750-Survival Analysis,
pubmed-meshheading:11583750-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.
|
|
pubmed:affiliation |
Erasmus University and Academic Hospital Rotterdam-Dijkzigt, Rotterdam, Netherlands. mickisch@urol.azr.nl
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|
